Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amy Liu

Showing results (241-250 of 269) with videos related to

Pageof 27
Sort By:
JAMA Oncology|January 7, 2021
Implementation and Outcomes of Virtual Care Across a Tertiary Cancer Center During COVID-19Alejandro Berlin, Mike Lovas, Tran Truong, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 23, 2026
A Randomized Trial of Rifaximin vs Low FODMAP Diet for Symptom Outcomes and Microbiome Changes in Irritable Bowel SyndromeAllen Lee, Krishna Rao, Prashant Singh, et al.
JAMA Network Open|January 19, 2024
Late Cardiac Toxic Effects Associated With Treatment Protocols for Hodgkin Lymphoma in ChildrenAndrea C Lo, Amy Liu, Qi Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 24, 2020
EVOLVE: A Multicenter Open-Label Single-Arm Clinical and Translational Phase II Trial of Cediranib Plus Olaparib for Ovarian Cancer after PARP Inhibition ProgressionStephanie Lheureux, Ana Oaknin, Swati Garg, et al.
Clinical Nutrition (Edinburgh, Scotland)|March 18, 2023
Differences between HbA<sub>1c</sub> and glucose-related variables in predicting weight loss and glycaemic changes in individuals with overweight and hyperglycaemia - The PREVIEW trialMarta P Silvestre, Mikael Fogelholm, Marta Alves, et al.
Frontiers in Oncology|August 30, 2023
Combination of clinical, radiomic, and "delta" radiomic features in survival prediction of metastatic gastroesophageal adenocarcinomaSatheesh Krishna, Andrew Sertic, Zhihui Amy Liu, et al.
Journal of Thoracic Disease|September 11, 2023
Recommended first-line management of asymptomatic brain metastases from EGFR mutant and ALK positive non-small cell lung cancer varies significantly according to specialty: an international survey of clinical practiceChin Heng Fong, Nicholas Meti, Timothy Kruser, et al.
JAMA Network Open|August 12, 2022
Health Care Utilization in the 6 Months Following SARS-CoV-2 InfectionSara Y Tartof, Deborah E Malden, In-Lu Amy Liu, et al.
International Journal of Radiation Oncology, Biology, Physics|July 1, 2023
The Feasibility of Quality Assurance in the TOPGEAR International Phase 3 Clinical Trial of Neoadjuvant Chemoradiation Therapy for Gastric Cancer (an Intergroup Trial of the AGITG/TROG/NHMRC CTC/EORTC/CCTG)Jelena Lukovic, Alisha J Moore, Mark T Lee, et al.
Gynecologic Oncology|March 31, 2023
DKK1 is a predictive biomarker for response to DKN-01: Results of a phase 2 basket study in women with recurrent endometrial carcinomaRebecca Arend, Jhalak Dholakia, Cesar Castro, et al.
Pageof 27

Showing results (241-250 of 269) with videos related to

Sort By:
Pageof 27
JAMA Oncology|January 7, 2021
Implementation and Outcomes of Virtual Care Across a Tertiary Cancer Center During COVID-19Alejandro Berlin, Mike Lovas, Tran Truong, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 23, 2026
A Randomized Trial of Rifaximin vs Low FODMAP Diet for Symptom Outcomes and Microbiome Changes in Irritable Bowel SyndromeAllen Lee, Krishna Rao, Prashant Singh, et al.
JAMA Network Open|January 19, 2024
Late Cardiac Toxic Effects Associated With Treatment Protocols for Hodgkin Lymphoma in ChildrenAndrea C Lo, Amy Liu, Qi Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 24, 2020
EVOLVE: A Multicenter Open-Label Single-Arm Clinical and Translational Phase II Trial of Cediranib Plus Olaparib for Ovarian Cancer after PARP Inhibition ProgressionStephanie Lheureux, Ana Oaknin, Swati Garg, et al.
Clinical Nutrition (Edinburgh, Scotland)|March 18, 2023
Differences between HbA<sub>1c</sub> and glucose-related variables in predicting weight loss and glycaemic changes in individuals with overweight and hyperglycaemia - The PREVIEW trialMarta P Silvestre, Mikael Fogelholm, Marta Alves, et al.
Frontiers in Oncology|August 30, 2023
Combination of clinical, radiomic, and "delta" radiomic features in survival prediction of metastatic gastroesophageal adenocarcinomaSatheesh Krishna, Andrew Sertic, Zhihui Amy Liu, et al.
Journal of Thoracic Disease|September 11, 2023
Recommended first-line management of asymptomatic brain metastases from EGFR mutant and ALK positive non-small cell lung cancer varies significantly according to specialty: an international survey of clinical practiceChin Heng Fong, Nicholas Meti, Timothy Kruser, et al.
JAMA Network Open|August 12, 2022
Health Care Utilization in the 6 Months Following SARS-CoV-2 InfectionSara Y Tartof, Deborah E Malden, In-Lu Amy Liu, et al.
International Journal of Radiation Oncology, Biology, Physics|July 1, 2023
The Feasibility of Quality Assurance in the TOPGEAR International Phase 3 Clinical Trial of Neoadjuvant Chemoradiation Therapy for Gastric Cancer (an Intergroup Trial of the AGITG/TROG/NHMRC CTC/EORTC/CCTG)Jelena Lukovic, Alisha J Moore, Mark T Lee, et al.
Gynecologic Oncology|March 31, 2023
DKK1 is a predictive biomarker for response to DKN-01: Results of a phase 2 basket study in women with recurrent endometrial carcinomaRebecca Arend, Jhalak Dholakia, Cesar Castro, et al.
Pageof 27